Auxilius, a provider of clinical trial financial management (CTFM) software, secures $10million in funding. SignalFire was leading the round. The money will be used by the business to increase operations and development initiatives.
It , led by CEO Adam Weisman and Erin Warner Guill, offers biopharma firms solutions to address the accounting, finance, and operational requirements of clinical trials.
Through study-level budgeting, planning, and financial closing, the company’s FP&A and accounting software helps sponsors to gain control over trial expenditures and clinical vendors by replacing manual processes.
Read also – IFS Acquired Copperleaf Technologies Inc
As of right now, the company collaborates with more than 50 sponsors, including established public companies and up-and-coming biotechs. In 2023, Repare, TG Therapeutics, Invivyd, and Trevi Therapeutics are among the new clients that joined the company.
About Auxilius
Leading cloud-based Clinical Trial Financial Management (CTFM) software supplier is Auxilius. Life Sciences organisations can benefit from advanced investigator spend analytics, faster clinical trial planning, and accurate and timely financial closing thanks to the Auxilius platform.
